Puma Biotechnology, Inc.
PBYI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401667
In the last 90 days, Puma Biotechnology, Inc. insiders filed 0 open-market purchases and 5 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $313.6M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Puma Biotechnology, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 102 | 1 | 104 | +3 |
| Shares | 30.3M | 400.0K | 29.9M | +37.1K (+0.1%) |
| Value | $92.2M | $1.22M | $86.1M | −$4.85M (−5.3%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Puma Biotechnology, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5.16M | 1.83% |
| Two Sigma Investments, LP | 166,451 | $479.0K | 0.00% |
| Gsa Capital Partners LLP | 138,943 | $400.0K | 0.05% |
| Western Standard LLC | 141,614 | $334.0K | 0.32% |
| FMR LLC | 64,692 | $186.0K | 0.00% |
| Franklin Resources Inc | 35,600 | $103.0K | 0.00% |
| Crestline Management, LP | 28,571 | $82.0K | 0.01% |
| Pitcairn Co | 27,558 | $79.0K | 0.01% |
| Mirabella Financial Services LLP | 25,500 | $73.0K | 0.01% |
| Mackenzie Financial Corp | 12,164 | $35.0K | 0.00% |
| Running Point Capital Advisors, LLC | 10,000 | $29.0K | 0.02% |
| Amalgamated Bank | 5,256 | $15.0K | 0.00% |
| Amalgamated Financial Corp. | 5,256 | $15.0K | 0.00% |
| Meeder Asset Management Inc | 2,078 | $6.00K | 0.00% |
| Money Concepts Capital Corp | 1,000 | $3.00K | 0.00% |
| GHP Investment Advisors, Inc. | 1,170 | $3.00K | 0.00% |
| Aquatic Capital Management LLC | 600 | $2.00K | 0.00% |
| The PNC Financial Services Group, Inc. | 123 | $0 | 0.00% |
| CWM, LLC | 57 | $0 | 0.00% |
| Quent Capital, LLC | 143 | $0 | 0.00% |
Sold out (17)
Institutions that held Puma Biotechnology, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Jacobs Levy Equity Management, Inc | 756,675 | $2.30M |
| Bank of Montreal | 557,538 | $1.82M |
| Marshall Wace, LLP | 396,967 | $1.21M |
| Nomura Holdings Inc | 105,103 | $322.0K |
| Walleye Trading LLC | 101,947 | $310.0K |
| HRT Financial LP | 80,077 | $243.0K |
| Simplex Trading, LLC | 78,512 | $238.0K |
| Squarepoint Ops LLC | 38,201 | $116.0K |
| Zebra Capital Management LLC | 25,058 | $76.0K |
| Pinnacle Wealth Planning Services, Inc. | 16,749 | $51.0K |
| Manteio Capital LLC | 16,409 | $50.0K |
| Wolverine Trading, LLC | 11,847 | $38.0K |
| Group One Trading, L.P. | 4,789 | $15.0K |
| TCI Wealth Advisors, Inc. | 1,429 | $4.00K |
| Quadrant Capital Group LLC | 586 | $2.00K |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 1 | $0 |
| KRS Capital Management, LLC | 58 | $0 |
Not filed for Q1 2022 yet (1)
Institutions that held Puma Biotechnology, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| AlphaCentric Advisors LLC | 400,000 | $1.22M |